242 related articles for article (PubMed ID: 16052104)
1. Efficacy and safety of heparinase I versus protamine in patients undergoing coronary artery bypass grafting with and without cardiopulmonary bypass.
Stafford-Smith M; Lefrak EA; Qazi AG; Welsby IJ; Barber L; Hoeft A; Dorenbaum A; Mathias J; Rochon JJ; Newman MF;
Anesthesiology; 2005 Aug; 103(2):229-40. PubMed ID: 16052104
[TBL] [Abstract][Full Text] [Related]
2. A dose-determining trial of heparinase-I (Neutralase) for heparin neutralization in coronary artery surgery.
Heres EK; Horrow JC; Gravlee GP; Tardiff BE; Luber J; Schneider J; Barragry T; Broughton R
Anesth Analg; 2001 Dec; 93(6):1446-52, table of contents. PubMed ID: 11726421
[TBL] [Abstract][Full Text] [Related]
3. Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass.
Levin AI; Heine AM; Coetzee JF; Coetzee A
J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):224-9. PubMed ID: 24461364
[TBL] [Abstract][Full Text] [Related]
4. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
[TBL] [Abstract][Full Text] [Related]
5. Heparin reversal in off-pump coronary artery bypass surgery: complete, partial, or no reversal?
Gatti G; Pugliese P
Cardiovasc Surg; 2002 Jun; 10(3):245-50. PubMed ID: 12044433
[TBL] [Abstract][Full Text] [Related]
6. Heparin Reversal After Cardiopulmonary Bypass: Are Point-of-Care Coagulation Tests Interchangeable?
Willems A; Savan V; Faraoni D; De Ville A; Rozen L; Demulder A; Van der Linden P
J Cardiothorac Vasc Anesth; 2016 Oct; 30(5):1184-9. PubMed ID: 27461795
[TBL] [Abstract][Full Text] [Related]
7. The effects of heparinase 1 and protamine on platelet reactivity.
Ammar T; Fisher CF
Anesthesiology; 1997 Jun; 86(6):1382-6. PubMed ID: 9197309
[TBL] [Abstract][Full Text] [Related]
8. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study.
Dyke CM; Smedira NG; Koster A; Aronson S; McCarthy HL; Kirshner R; Lincoff AM; Spiess BD
J Thorac Cardiovasc Surg; 2006 Mar; 131(3):533-9. PubMed ID: 16515902
[TBL] [Abstract][Full Text] [Related]
9. The effect of protamine dosing variation on bleeding and transfusion after heparinisation for cardiopulmonary bypass.
Kunz SA; Miles LF; Ianno DJ; Mirowska-Allen KL; Matalanis G; Bellomo R; Seevanayagam S
Perfusion; 2018 Sep; 33(6):445-452. PubMed ID: 29544405
[TBL] [Abstract][Full Text] [Related]
10. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation with bivalirudin for off-pump coronary artery bypass grafting: the results of the EVOLUTION-OFF study.
Smedira NG; Dyke CM; Koster A; Jurmann M; Bhatia DS; Hu T; McCarthy HL; Lincoff AM; Spiess BD; Aronson S
J Thorac Cardiovasc Surg; 2006 Mar; 131(3):686-92. PubMed ID: 16515924
[TBL] [Abstract][Full Text] [Related]
12. A comparison of thromboelastography with heparinase or protamine sulfate added in vitro during heparinized cardiopulmonary bypass.
Spiess BD; Wall MH; Gillies BS; Fitch JC; Soltow LO; Chandler WL
Thromb Haemost; 1997 Aug; 78(2):820-6. PubMed ID: 9268178
[TBL] [Abstract][Full Text] [Related]
13. Heparinase I (neutralase) reversal of systemic anticoagulation.
Michelsen LG; Kikura M; Levy JH; Lee MK; Lee KC; Zimmermann JJ; Szlam F
Anesthesiology; 1996 Aug; 85(2):339-46. PubMed ID: 8712450
[TBL] [Abstract][Full Text] [Related]
14. Pilot validation of an individualised pharmacokinetic algorithm for protamine dosing after systemic heparinisation for cardiopulmonary bypass.
Miles LF; Marchiori P; Falter F
Perfusion; 2017 Sep; 32(6):481-488. PubMed ID: 28820026
[TBL] [Abstract][Full Text] [Related]
15. Use of heparinase I in a patient with protamine allergy undergoing redo myocardial revascularization.
Ralley FE; De Varennes B
J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):710-1. PubMed ID: 11139116
[No Abstract] [Full Text] [Related]
16. Effects of differing rates of protamine reversal of heparin anticoagulation.
Wakefield TW; Hantler CB; Wrobleski SK; Crider BA; Stanley JC
Surgery; 1996 Feb; 119(2):123-8. PubMed ID: 8571194
[TBL] [Abstract][Full Text] [Related]
17. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
[TBL] [Abstract][Full Text] [Related]
18. Complete Heparin Reversal by Protamine during Off-Pump Coronary Artery Bypass Surgery (OPCAB): A Necessity or Myth?
Dasgupta S; Samad A; Howlader SS; Choudhury DI; Hossain A; Khan MS; Hasan MR; Talukder QI; Rahman MK
Mymensingh Med J; 2023 Apr; 32(2):421-429. PubMed ID: 37002753
[TBL] [Abstract][Full Text] [Related]
19. Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?
Teoh KH; Young E; Blackall MH; Roberts RS; Hirsh J
J Thorac Cardiovasc Surg; 2004 Aug; 128(2):211-9. PubMed ID: 15282457
[TBL] [Abstract][Full Text] [Related]
20. Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial.
Arsenault KA; Paikin JS; Hirsh J; Dale B; Whitlock RP; Teoh K; Young E; Ginsberg JS; Weitz JI; Eikelboom JW
J Thorac Cardiovasc Surg; 2012 Oct; 144(4):944-950.e3. PubMed ID: 22743176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
